Please enable Javascript and disable ad blockers

Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Nordea Bank Abp: Transaction in Own SharesPhoto, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

Nordea Bank Abp: Transaction in Own Shares

Nordea Bank Abp: Transaction in Own Shares

0

EQS-News: tokentus investment AG bought XRP coins for 50,000 euros and thus expands its investment in Ripple

EQS-News: tokentus investment AG bought XRP coins for 50,000 euros and thus expands its investment in Ripple

EQS-News: tokentus investment AG bought XRP coins for 50,000 euros and thus expands its investment in Ripple

0

EQS-News: Accelerated patient recruitment; adapted study protocol meets expectations for human clinical trial of breakthrough silver antibacterial coating technology Photo, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

EQS-News: Accelerated patient recruitment; adapted study protocol meets expectations for human clinical trial of breakthrough silver antibacterial coating technology

EQS-News: Accelerated patient recruitment; adapted study protocol meets expectations for human clinical trial of breakthrough silver antibacterial coating technology

0

Arbonia further improves competitiveness by consolidating design radiator productionPhoto, wide shot, wide-angle lens, Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png

Arbonia further improves competitiveness by consolidating design radiator production

Arbonia further improves competitiveness by consolidating design radiator production

0

Trading update – Slump in building permits due to construction cost increases and interest rate hikesPhoto, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://img.midjourneyapi.xyz/temp/568784d0-c41a-4663-ab01-91f29a370903.png

Trading update – Slump in building permits due to construction cost increases and interest rate hikes

Trading update – Slump in building permits due to construction cost increases and interest rate hikes

0

Mikron Group again significantly improves sales and profitabilityPhoto, wide shot, wide-angle lens, Aerospace components, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/3938f51e-9b01-45a9-aed1-ff9d047063fc.png

Mikron Group again significantly improves sales and profitability

Mikron Group again significantly improves sales and profitability

0

Press release: Leonteq publishes half-year 2023 resultsPhoto, wide shot, wide-angle lens, soft focus, IT consulting firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Sebastião Salgado: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-uhXP0RHYYxDepjmHeSp1K8bF.png?st=2023-05-07T15%3A26%3A44Z&se=2023-05-07T17%3A26%3A44Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-07T16%3A18%3A55Z&ske=2023-05-08T16%3A18%3A55Z&sks=b&skv=2021-08-06&sig=4pcJOd8aEI1799liUV13F4ElqO7e4RZy8sa1PEeeNZA%3D

Press release: Leonteq publishes half-year 2023 results

Press release: Leonteq publishes half-year 2023 results

0

Cembra reports solid half-year resultsPhoto, wide shot, wide-angle lens, soft focus, Asset management firm, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-4Gf80r47YD589EFtjlMy4oXE.png?st=2023-05-06T14%3A52%3A24Z&se=2023-05-06T16%3A52%3A24Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-06T00%3A39%3A24Z&ske=2023-05-07T00%3A39%3A24Z&sks=b&skv=2021-08-06&sig=d8x8qxYEsZ8AfRwcBw8eUkxkNQFVf9GobJgEag27Xug%3D

Cembra reports solid half-year results

Cembra reports solid half-year results

0

Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19

Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19

Biophytis: Biophytis has requested a pre-submission meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the treatment of COVID-19

0

Zehnder Group achieved solid sales and EBIT again in the first half of 2023; adjusted outlook for the 2023 financial yearPhoto, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png

Zehnder Group achieved solid sales and EBIT again in the first half of 2023; adjusted outlook for the 2023 financial year

Zehnder Group achieved solid sales and EBIT again in the first half of 2023; adjusted outlook for the 2023 financial year

0

Q2 2023 resultsPhoto, wide shot, wide-angle lens, Aerospace components, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/3938f51e-9b01-45a9-aed1-ff9d047063fc.png

Q2 2023 results

Q2 2023 results

0

Rieter: First Half of 2023

Ad-hoc announcement pursuant to Art. 53 LRPhoto, wide shot, wide-angle lens, Construction equipment, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/96af5505-e3c8-4496-bbb7-e4a5eba91e77.png

Rieter: First Half of 2023 Ad-hoc announcement pursuant to Art. 53 LR

Rieter: First Half of 2023 Ad-hoc announcement pursuant to Art. 53 LR

0

Semi Annual Report 2023

Ad hoc announcement pursuant to Art. 53 LRPhoto, wide shot, wide-angle lens, Metal fabrication, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.midjourneyapi.xyz/temp/138548fd-aba2-4b3e-b9ee-93725b372952.png

Semi Annual Report 2023 Ad hoc announcement pursuant to Art. 53 LR

Semi Annual Report 2023 Ad hoc announcement pursuant to Art. 53 LR

0

EQS-Adhoc: HelloFresh SE expects to have achieved highest ever quarterly adjusted EBITDA (“AEBITDA”) in Q2 2023, materially above market expectationsPhoto, wide shot, wide-angle lens, Convenience store, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.midjourneyapi.xyz/temp/35bdb659-cf5a-466a-95a9-428a230a2d2e.png

EQS-Adhoc: HelloFresh SE expects to have achieved highest ever quarterly adjusted EBITDA (“AEBITDA”) in Q2 2023, materially above market expectations

EQS-Adhoc: HelloFresh SE expects to have achieved highest ever quarterly adjusted EBITDA (“AEBITDA”) in Q2 2023, materially above market expectations

0

EQS-Adhoc: Daimler Truck Holding AG: Preliminary results for Q2 2023 above expectations: https://upload.wikimedia.org/wikipedia/commons/thumb/5/55/Daimler_Truck_Logo.svg/1024px-Daimler_Truck_Logo.svg.png

EQS-Adhoc: Daimler Truck Holding AG: Preliminary results for Q2 2023 above expectations

EQS-Adhoc: Daimler Truck Holding AG: Preliminary results for Q2 2023 above expectations

0

EQS-Adhoc: Leifheit Aktiengesellschaft: Preliminary earnings before interest and taxes (EBIT) and preliminary free cash flow in Q2 2023 and H1 2023 significantly above previous year’s figuresPhoto, wide shot, wide-angle lens, Clothing manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.midjourneyapi.xyz/temp/7d69264d-49b2-466c-9987-b2706836d522.png

EQS-Adhoc: Leifheit Aktiengesellschaft: Preliminary earnings before interest and taxes (EBIT) and preliminary free cash flow in Q2 2023 and H1 2023 significantly above previous year’s figures

EQS-Adhoc: Leifheit Aktiengesellschaft: Preliminary earnings before interest and taxes (EBIT) and preliminary free cash flow in Q2 2023 and H1 2023 significantly above previous year’s figures

0

Rights and Issues Investment Trust PLC: POS-Transaction in Own SharesPhoto, wide shot, wide-angle lens, Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png

Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares

Rights and Issues Investment Trust PLC: POS-Transaction in Own Shares

0

Fix Price Group PLC: Notification of PDMR transaction

Fix Price Group PLC: Notification of PDMR transaction

Fix Price Group PLC: Notification of PDMR transaction

0

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionPhoto, wide shot, wide-angle lens, Retail store, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/bda07ced-e79e-4489-b731-ada601660c8e.png

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

0

Hudson And The House Of LR&C Open First Airport Location For The CompanyPhoto, wide shot, wide-angle lens, Online marketplace, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/27d484d8-d1b1-4519-9797-b5dcaa68d4e2.png

Hudson And The House Of LR&C Open First Airport Location For The Company

Hudson And The House Of LR&C Open First Airport Location For The Company

0

EQS-News: Noratis AG: Noratis AG annual general meeting passes all agenda items with a large majority

EQS-News: Noratis AG: Noratis AG annual general meeting passes all agenda items with a large majority

EQS-News: Noratis AG: Noratis AG annual general meeting passes all agenda items with a large majority

0

Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)

Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)

Chelverton UK Dividend Trust plc: NAV-Net Asset Value(s)

0

Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)Photo, wide shot, wide-angle lens, Hedge fund, neutral atmosphere, photo by Charlie Waite: https://img.theapi.app/temp/95282efd-f725-49c0-be40-aa74627f7ccc.png

Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)

Rights and Issues Investment Trust PLC: NAV-Net Asset Value(s)

0

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plcPhoto, wide shot, wide-angle lens, soft focus, Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc

0

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc

0